Instil Bio, Inc. (TIL)

Instil Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.64	8.81	9.2	43.72	37.59
Short-Term Investments	69.49	104.51	141.16	217.2	416.51
Cash & Short-Term Investments	76.13	113.32	150.36	260.92	454.1
Cash Growth	-32.82%	-24.64%	-42.38%	-42.54%	87.87%
Other Current Assets	115.3	11.16	10.4	8.46	9.92
Total Current Assets	191.43	124.47	160.76	269.38	464.02
Net Property, Plant & Equipment	0.36	130.34	141.07	209.34	122
Other Intangible Assets	-	-	-	-	10.1
Goodwill	-	-	-	-	5.72
Long-Term Investments	-	-	23.16	-	-
Other Long-Term Assets	11.73	8.76	0.64	3.41	8.14
Total Assets	203.52	263.57	325.63	482.13	609.98
Accounts Payable	0.78	0.66	1.21	2.36	5.57
Other Current Liabilities	4.06	7.24	9.35	30.07	34.45
Total Current Liabilities	4.84	7.9	10.56	32.79	41.36
Long-Term Debt	84.81	84.19	81.43	72.35	-
Long-Term Leases	-	1.02	2.88	5.17	-
Other Long-Term Liabilities	0.01	1.03	4.94	8.57	14.77
Total Long-Term Liabilities	84.81	86.24	89.24	86.1	14.77
Total Liabilities	89.66	94.13	99.8	118.52	54.78
Additional Paid-in Capital	840.94	824.78	807.16	788.99	757
Accumulated Other Comprehensive Income	-0.58	-0.23	-0.35	-0.49	-0.09
Retained Earnings	-726.49	-655.12	-580.98	-424.89	-201.72
Shareholders' Equity	113.87	169.44	225.83	363.61	555.2
Total Liabilities & Equity	203.52	263.57	325.63	482.13	609.98
Total Debt	84.81	85.2	84.3	77.52	0
Net Cash (Debt)	-8.68	28.11	66.05	183.4	454.1
Net Cash Growth	-	-57.44%	-63.98%	-59.61%	87.87%
Net Cash Per Share	-1.30	4.32	10.16	28.32	85.69
Book Value	113.87	169.44	225.83	363.61	555.2
Book Value Per Share	17.08	26.03	34.72	56.15	104.76
Tangible Book Value	113.87	169.44	225.83	363.61	539.37
Tangible Book Value Per Share	17.08	26.03	34.72	56.15	101.77

Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q